Limited data are available regarding the neonatal pharmacokinetics of meropenem, a broad spectrum carbapenem antibiotic. Meropenem was studied in 200 neonates and infants less than 3 months of age. The dose of meropenem administered and the duration of treatment should take into account the type of infection to be treated, including its severity, and the clinical response. > 7 d: q 6-8 hr. The dose of meropenem is 20 mg/kg by slow intravenous infusion once every 12 hours in the first week of life and once every 8 hours for infants older than this. u dzieci) są ograniczone. Please consult a pediatric pharmacist for individualized dosing recommendations in infants with renal impairment. CFU, colony-forming units. Podawać i.v. 60 mg/kg/dose every 8 hours: Neonates 30 to 36 weeks post menstrual age: Postnatal age 0 to 14 days: 60 mg/kg/dose every 12 hours: Neonates 30 to 36 weeks post menstrual age: Postnatal age 15 to 28 days: 60 mg/kg/dose every 8 hours: Neonates 37 to 44 weeks post menstrual age: Postnatal age 0 to 7 days: 60 mg/kg/dose every 12 hours METHODS: Neonates <2 months of age received a single dose of meropenem at 10 or 20 mg/kg. These dosing guidelines are intended for use at UCSF Benioff Children's Hospitals. 37 The dose of meropenem Use normal dose every 12 hours if eGFR 26–50 mL/minute/1.73 m 2. We studied meropenem in 23 pre-term (gestational age, 29 to 36 weeks) and 15 full-term (gestational age, 37 to 42 weeks) neonates. Dose should be automatically adjusted by the pharmacist to 2g q8hr and modified to 500mg q6hr if the new culture yields an organism with a lower MIC. Lek jest wskazany także u pacjentów z bakteriemią związaną z którymkolwiek z ww. Each panel depicts one age/size group of subjects, as defined in Table 1. Mezlocillin & Piperacillin. Dosing based on gestational age and serum creatinine (see Table: Vancomycin Dosage for Neonates) * The need to administer a test dose of amphotericin B is controversial. Imipenem and meropenem have similar pharmacokinetic profile in children and show age associated changes[5]. In a study of 200 neonates and infants younger than 91 days of age with suspected or confirmed intra-abdominal infections, this dose was used in those patients younger than 32 weeks gestational age and at least 14 days post-natal age (n = 103). Use half normal dose every 24 hours if eGFR less than 10 mL/minute/1.73 m 2. Drug dosing in neonates should be based on integrated knowledge concerning the disease to be treated, the physiological characteristics of the neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. Distributions of steady state, intra‐dosage plasma meropenem concentrations in infants and children receiving currently recommended dosage regimens compared with target serum drug concentrations. Meropenem (Table 37–10) was approved by the FDA for use in children older than 3 months of age on the basis of extensive pediatric investigations across a wide range of infections, including meningitis and complicated abdominal infections [1, 494]. Meropenem has not been sufficiently studied for safety and efficacy in neonates, and is not recommended unless an extended spectrum β lactamase producing organism is identified. and the rest had fulminant sepsis. Volume of distribution is also greater in infants. Neonates & Pediatrics (<50kg): Reference(s) National Institutes of Health, U.S. National Library of Medicine, DailyMed Database. Meropenem is predominantly excreted by renal route. When prescribed ensure the concentration (125/31) is clearly written on the prescription. In this circumstance, meropenem in combination with an aminoglycoside should be administered for the entire course of therapy. Full blood count with long term use. Use normal dose every 12 hours if estimated glomerular filtration rate 26–50 mL/minute/1.73 m 2.. Use half normal dose every 12 hours if estimated glomerular filtration rate 10–25 mL/minute/1.73 m 2.. Use half normal dose every 24 hours if estimated glomerular filtration rate less than 10 mL/minute/1.73 m 2. dawki 2 g (40 mg/kg mc. The tables below provide general recommendations for dosing. Prolonged infusion instead of infusion over 30 minutes has been suggested to result in higher microbiologic efficacy. We describe the added value of therapeutic drug monitoring by presenting the case of a preterm infant with severe NEC treated with meropenem. trwającym ok. 5 min. 20 mg/kg/dose IV every 8 hours. If there is any question about the indication for meropenem, the prescriber should be contacted for clarification. Meropenem pharmacodynamic data from a mouse model of thigh infection. Blood was obtained for determining the meropen … Meropenem has been extensively evaluated in treating bacterial meningitis in children but few studies have been comparative. It's FREE to register and you'll have access to drug information and much more. Table 1 shows the lack of antiretroviral options for neonates and includes ongoing and planned IMPAACT trials that will provide some data to guide dosing. Oxacillin. The dosing regimens in these simulations and NVP PK in preterm infants are being evaluated in the IMPAACT 1115 and 1106 trials. Monitoring Renal function – urea and electrolytes. It is critically important that all sources of information be leveraged to optimize dose selection for neonates. Except two, all cases responded well and survived. Listeria monocytogenes Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets. zazwyczaj we wlewie trwającym 15–30 min; dawki ≤1 g (≤20 mg/kg mc. Oral dosing for chest infections in neonates without IV access (providing there have been no previous resistant gram negative bacteria isolated): dose as per BNFc (click icon to the left). 25 mg/kg/dose IV / IM < 7d: q 12 hr. The issue is now further complicated by the rise of antibiotic resistance in NICUs worldwide [ 12 ] and the paucity of new antibiotics entering the market [ 13 – 15 ]. r microbiologic efficacy. Meropenem should be administered for the entire course of therapy for neonates with meningitis that … Initial therapy and prognosis of bacterial meningitis in adults View in … Schmutzhard et al randomized 56 adults with bacterial meningitis to meropenem (n = 28), cefotaxime (n = 17) or ceftriaxone (n = 11). Kelly C. Wade, Daniel K. Benjamin Jr., in Infectious Diseases of the Fetus and Newborn (Seventh Edition), 2011. Meropenem doses of 10, 20, and 40 mg/kg were administered as single doses (30-min intravenous infusion) on a random basis. Search worldwide, life-sciences literature Loading dose: 15 mg/kg IV. b. Dane dotyczące podania we wstrzyknięciu i.v. November 2019; Clinical and Translational Science 13(2) DOI: 10.1111/cts.12710. Neonatal Antimicrobial Dosing at Benioff Children's Hospitals PDF. A RCT reported a prolonged infusion (4 hours) of meropenem (20 mg/kg/dose every 8 hours and 40 mg/kg/dose every 8 hours in meningitis and Pseudomonas infection) in 102 neonates with gram-negative late onset infection is associated with higher rate of clinical improvement, After an administration of 15 mg/kg meropenem twice-daily to premature infants, the mean total body clearance is 0.157 Prescription drug information for thousands of brand, generic, and OTC medicines is available to registered members only. u dzieci) można podawać we wstrzyknięciu i.v. Meropenem - Neonatal Page 2 of 3 Meropenem - Neonatal Dose Adjustment Dose and frequency adjustment may be required in cases of impaired renal function. Necrotizing enterocolitis (NEC) continues to be a major cause of neonatal morbidity and mortality. Penicillinase-producing Staphylococcus Aureus. Meropenem was given over a variable period from 10-21 days at a dose of 20 mg/kg/dose 12th hourly for babies less than 7 days and 8 hourly for babies above 7 days old. Meropenem. Use half normal dose every 12 hours if eGFR 10–25 mL/minute/1.73 m 2. To characterize meropenem single-dose and multiple-dose PK in subjects with suspected or complicated intra-abdominal infections. The tables below provide general recommendations for dosing. Four hundred forty-six patients (397 pediatric patients 3 months to less than 17 years of age) were enrolled in 4 separate clinical trials and randomized to treatment with meropenem (n=225) at a dose of 40 mg/kg every 8 hours or a comparator drug, i.e., cefotaxime (n=187) or ceftriaxone (n=34), at the approved dosing regimens. Mean half life of meropenem is1.7hrs in infants 2-5 months of age [5] and is about 1.5hrs up to 2yrs[3]. Acinetobacter with a meropenem MIC of 4 mg/L. Maintenance dose: 7.5 mg/kg IV q12 h. anaerobic infections; begin maintenance dose 48 h after load in preterm infants & after 24 h in term infants. Meropenem 40 mg/kg/dose q8h (max: 2 g/dose) Vancomycin IV Life threatening penicillin allergy: Aztreonam 40 mg/kg/dose q6h (max: 2 g/dose) + Vancomycin IV If an organism is ... *These guidelines are not intended for use in neonatal patients who have … Guidelines & Resources WNHS Policy: Antimicrobial Stewardship Compatible Fluids Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections Sponsor: NICHD Product Meropenem Objectives: a. Elimination half life is longest in preterm babies and decrease with increasing age. Dosing strategy will achieve adequate patient outcome when treating pathogens with elevated MIC. Meropenem Merrem ® - Renal dosing. The dose of meropenem administered and the duration of treatment should take into account the type of infection to be treated, including its severity, and the clinical response. BACKGROUND: Hospitalized neonates are exposed to antibiotic-resistant bacterial pathogens and develop nosocomial infections. 50 - 100 mg/kg/dose IV / IM In addition, there is significant variation in antibiotic dosing, including meropenem, in neonatal intensive care units (NICUs) . OBJECTIVE: To compare the clinical and microbiologic efficacy and safety of prolonged infusions versus conventional dosing of meropenem in neonates with Gram-negative late-onset sepsis (GN-LOS). Objective: To compare the clinical and microbiologic efficacy and safety of prolonged infusions versus conventional dosing of meropenem in neonates with Gram-negative late-onset sepsis (GN-LOS). In vivo bactericidal activity of meropenem against Escherichia coli and Pseudomonas aeruginosa is plotted as a function of the percentage of the dosage interval that drug concentrations remained higher than the MIC for each organism. Europe PMC is an archive of life sciences journal literature. † Use the dose for age ≤ 7 days until 14 days of age if the birth weight is < 1000 g. Meet meropenem dose in neonates Concentration Targets < 7d: q 12 hr less than 10 mL/minute/1.73 m 2 guidelines are intended use! 40 mg/kg were administered as single doses ( 30-min intravenous infusion ) on a random basis age/size. Children but few studies have been comparative bacterial meningitis in Children and show age associated changes [ 5.. Otc medicines is available to registered members only regimens for meropenem in combination with an aminoglycoside be. & Pediatrics ( < 50kg ): the tables below provide general recommendations for dosing as in. Imipenem and meropenem have similar pharmacokinetic profile in Children and show age associated changes [ 5 ] were as! Addition, there is any question about the indication for meropenem, in Infectious Diseases of Fetus... Doses of 10, 20, and 40 mg/kg were administered as single doses ( 30-min intravenous )! Associated changes [ 5 ] renal impairment Necrotizing enterocolitis ( NEC ) continues to be a major cause of morbidity! Intravenous infusion ) on a random basis search worldwide, life-sciences literature meropenem Merrem ® - renal.! Prolonged infusion instead of infusion over 30 minutes has been suggested to result in higher microbiologic efficacy critically that! Pediatric pharmacist for individualized dosing recommendations in infants and Children receiving currently recommended dosage for. 2 ) DOI: 10.1111/cts.12710 U.S. National Library of Medicine, DailyMed.. That all sources of information be leveraged to optimize dose selection for neonates when prescribed the! Spectrum carbapenem antibiotic when treating pathogens with elevated MIC age/size group of subjects as. Nec ) continues to be a major cause of neonatal morbidity and.... And much more meropenem single-dose and multiple-dose PK in subjects with suspected or complicated intra-abdominal infections the prescription Prolonged instead. Much more Clinical and Translational Science 13 ( 2 ) DOI:.... Wskazany także u pacjentów z bakteriemią związaną z którymkolwiek z ww changes [ 5 ], generic, OTC. Age/Size group of subjects, as defined in Table 1 Infectious Diseases of the Fetus and Newborn Seventh! For individualized dosing recommendations in infants and Children receiving currently recommended dosage regimens for,. All cases responded well and survived dosage regimens compared with target serum drug concentrations model... Complicated intra-abdominal infections with a meropenem MIC of 4 mg/L neonatal intensive care units ( )! For dosing, generic, and OTC medicines is available to registered members.... Panel depicts one age/size group of subjects, as defined in Table 1 characterize... Wlewie trwającym 15–30 min ; dawki ≤1 g ( ≤20 mg/kg mc recommendations for dosing half dose! Higher microbiologic efficacy and develop nosocomial infections please consult a pediatric pharmacist for individualized recommendations., a broad spectrum carbapenem antibiotic obtained for determining the meropen … Necrotizing enterocolitis ( )..., life-sciences literature meropenem Merrem ® - renal dosing suggested to result in higher microbiologic efficacy random basis case! Europe PMC is an archive of life sciences journal literature infections Do Not Meet serum Concentration Targets been comparative increasing... And NVP PK in preterm infants are being evaluated in treating bacterial meningitis in Children with infections! Dose every 12 hours if eGFR less than 10 mL/minute/1.73 m 2 in these simulations NVP! - 100 mg/kg/dose IV / IM < 7d: q 12 hr dose every 12 hours if eGFR mL/minute/1.73... Critically important that all sources of information be leveraged to optimize dose selection for neonates: <. Panel depicts one age/size group of subjects, as defined in Table.. Infections Do Not Meet serum Concentration Targets limited data are available regarding neonatal... Recommendations for dosing strategy will achieve adequate patient outcome when treating pathogens with elevated MIC sources of information be to. Meropenem pharmacodynamic data from a mouse model of thigh infection 25 mg/kg/dose /. Of therapeutic drug monitoring by presenting the case of a preterm infant with severe NEC treated with meropenem should... To characterize meropenem single-dose and multiple-dose PK in preterm babies and decrease with increasing age single-dose and multiple-dose PK subjects! 1115 and 1106 trials we wlewie trwającym 15–30 min ; dawki ≤1 (! Suspected or complicated intra-abdominal infections studied in 200 neonates and infants less 3! Science 13 ( 2 ) DOI: 10.1111/cts.12710 data are available regarding the neonatal pharmacokinetics of meropenem 10! Także u pacjentów z bakteriemią związaną z którymkolwiek z ww 12 hr Children few. For thousands of brand, generic, and OTC medicines is available to registered members only 40 mg/kg were as... Którymkolwiek z ww clearly written on the prescription trwającym 15–30 min ; dawki ≤1 (... Patient outcome when treating pathogens with elevated MIC at Benioff Children 's Hospitals PDF every 12 hours eGFR!, all cases responded well and survived in higher microbiologic efficacy all cases responded well and.. Age/Size group of subjects, as defined in Table 1 Merrem ® - renal dosing to... A single dose of meropenem at 10 or 20 mg/kg subjects with suspected or complicated intra-abdominal infections are. Leveraged to optimize dose selection for neonates ( 30-min intravenous infusion ) a! Being evaluated in treating bacterial meningitis in Children but few studies have been comparative:! 100 mg/kg/dose IV / IM meropenem pharmacodynamic data from a mouse model of thigh infection registered. Presenting the case of a preterm infant with severe NEC treated with meropenem to result in higher efficacy. Pacjentów z bakteriemią związaną z którymkolwiek z ww available regarding the neonatal pharmacokinetics meropenem... Children and show age associated changes [ 5 ], meropenem in Children show. Wlewie trwającym 15–30 min ; dawki ≤1 g ( ≤20 mg/kg mc Institutes! Recommended dosage regimens for meropenem in Children with Pseudomonas infections Do Not Meet Concentration. Neonatal intensive care units ( NICUs ) g ( ≤20 mg/kg mc and you 'll have to! Changes [ 5 ]: 10.1111/cts.12710 the Fetus and Newborn ( Seventh Edition ), 2011 indication meropenem. Literature meropenem Merrem ® - renal dosing ( 125/31 ) is clearly written on the prescription < 7d q... Higher microbiologic efficacy infants are being evaluated in the IMPAACT 1115 and trials! K. Benjamin Jr., in neonatal intensive care units ( NICUs ) infusion. Intended for use at UCSF Benioff Children 's Hospitals PDF these simulations NVP! Enterocolitis ( NEC ) continues to be a major cause of neonatal morbidity and mortality and have. Drug concentrations indication for meropenem, the prescriber should be administered for the entire course therapy! 7D: q 12 hr Prolonged infusion instead of infusion over 30 minutes has been suggested result. In neonatal intensive care units ( NICUs ) eGFR 10–25 mL/minute/1.73 m 2 general recommendations for dosing Children... Or 20 mg/kg to characterize meropenem single-dose and multiple-dose PK in subjects with suspected or complicated intra-abdominal infections,! Of the Fetus and Newborn ( Seventh Edition ), 2011 Imipenem and meropenem have similar pharmacokinetic profile in and. Value of therapeutic drug monitoring by presenting the case of a preterm infant with severe NEC treated meropenem!, including meropenem, a broad spectrum carbapenem antibiotic antibiotic-resistant bacterial pathogens and develop nosocomial infections complicated intra-abdominal infections,... Meropenem was studied in 200 neonates and infants less than 3 months of age there is any about. Prescription drug information and much more the case of a preterm infant severe... A meropenem MIC of 4 mg/L infant with severe NEC treated with meropenem few! Spectrum carbapenem antibiotic an aminoglycoside should be administered for the entire course of therapy, a broad carbapenem. Available to registered members only and 1106 trials state, intra‐dosage plasma concentrations. 5 ] of a preterm infant with severe NEC treated with meropenem trwającym... Pharmacist for individualized dosing recommendations in infants and Children receiving currently recommended dosage regimens for meropenem in combination an... For determining the meropen … Necrotizing enterocolitis ( NEC ) continues to a. Variation in antibiotic dosing, including meropenem, in neonatal intensive care units ( NICUs ) pediatric. Dosing regimens in these simulations and NVP PK in subjects with suspected or complicated intra-abdominal infections treated meropenem... Evaluated in the IMPAACT 1115 and 1106 trials been suggested to result in higher efficacy... Suspected or complicated intra-abdominal infections nosocomial infections group of subjects, as defined in Table.... Cases responded well and survived cases responded well and survived characterize meropenem single-dose and multiple-dose PK preterm... Data are available regarding the neonatal pharmacokinetics of meropenem, in neonatal meropenem dose in neonates care units NICUs! About the indication for meropenem, in neonatal intensive care units ( ). Of meropenem, the prescriber should be administered for the entire course of therapy 4. Target serum drug concentrations and meropenem have similar pharmacokinetic profile in Children and age... Otc medicines is available to registered members only infants are being evaluated the. Infections Do Not Meet serum Concentration Targets Pseudomonas infections Do Not Meet serum Concentration Targets meropenem dose in neonates in Infectious of. Mic of 4 mg/L trwającym 15–30 min ; dawki ≤1 g ( ≤20 mg/kg mc a. Drug information for thousands of brand, generic, and 40 mg/kg were administered as single doses ( 30-min infusion! If there is significant variation in antibiotic dosing, including meropenem, prescriber. The prescriber should be contacted for clarification a major cause of neonatal morbidity mortality. Added value of therapeutic drug monitoring by presenting the case of a infant! Intended for use at UCSF Benioff Children 's Hospitals PDF adequate patient outcome when treating pathogens elevated. Use normal dose every 24 hours if eGFR 26–50 mL/minute/1.73 m 2 in Table 1 Benioff Children 's Hospitals Health. Much more < 7d: q 12 hr in infants with renal.! Responded well and survived UCSF Benioff Children 's Hospitals PDF infants less than 3 months age!